Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Phio Pharmaceuticals Corp (PHIO)

Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Phio Pharmaceuticals Corp 411 SWEDELAND ROAD SUITE 23-1080 KING OF PRUSSIA PA 19406 USA

https://phiopharma.com Employees: 5 P: 610-947-0251

Sector:

Medical

Description:

Phio Pharmaceuticals Corp is focused on developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi therapeutic platform. The Company's pipeline consists of RXI-762 and RXI-804 which are in clinical stage. Phio Pharmaceuticals Corp, formerly known as RXi Pharmaceuticals Corporation, is based in Marlborough, United States.

Key Statistics

Overview:

Market Capitalization, $K 12,056
Enterprise Value, $K 6,676
Shares Outstanding, K 10,764
Annual Sales, $ 0 K
Annual Net Income, $ -7,150 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,390 K
EBIT, $ -8,360 K
EBITDA, $ -8,300 K
60-Month Beta 0.92
% of Insider Shareholders 0.89%
% of Institutional Shareholders 57.31%
Float, K 10,668
% Float 99.11%
Short Volume Ratio 0.29

Growth:

1-Year Return -60.99%
3-Year Return -97.28%
5-Year Return -99.60%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 99.57%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.44 on 11/13/25
Next Earnings Date 03/30/26
Earnings Per Share ttm -2.15
EPS Growth vs. Prev Qtr 2.22%
EPS Growth vs. Prev Year 71.43%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-9 on 07/05/24

PHIO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -86.38%
Return-on-Assets % -75.77%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.69
Book Value/Share 1.70
Interest Coverage -0.91
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar